FATE THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fate Therapeutics Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Fate Therapeutics Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 114M shares, a 15.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 114M +15.3M +15.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 114M +15.3M +15.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 114M +15.6M +15.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 98.6M +1.33M +1.37% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 98.6M +1.47M +1.52% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 98.5M +1.66M +1.71% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 98.2M +1.65M +1.71% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 97.3M +1.57M +1.64% Dec 31, 2022 10-K 2024-02-26
Q3 2022 97.1M +1.75M +1.84% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 96.9M +2.6M +2.76% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 96.5M +2.65M +2.82% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 95.7M +8M +9.13% Dec 31, 2021 10-K 2023-02-28
Q3 2021 95.4M +8.36M +9.61% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 94.3M +7.46M +8.6% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 93.9M +17.9M +23.5% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 87.7M +12M +15.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 87M +11.6M +15.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 86.8M +21.5M +32.9% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 76M +10.9M +16.7% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 75.7M +11M +17.1% Dec 31, 2019 10-K 2021-02-24
Q3 2019 75.4M +10.9M +16.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 65.3M +11.9M +22.3% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 65.1M +12.3M +23.2% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 64.7M +12M +22.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 64.5M +23M +55.6% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 53.4M +12M +28.9% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 52.9M +11.5M +27.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 52.6M +11.3M +27.2% Dec 31, 2017 10-K 2019-03-05
Q3 2017 41.5M +7.31M +21.4% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 41.4M +12.5M +43.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 41.4M +12.5M +43.4% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 41.4M +12.7M +44.1% Dec 31, 2016 10-K 2018-03-05
Q3 2016 34.1M +5.43M +18.9% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 28.9M +265K +0.92% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 28.9M +8.22M +39.9% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 28.7M +8.15M +39.6% Dec 31, 2015 10-K 2017-03-16
Q3 2015 28.7M +8.15M +39.6% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 28.6M +8.06M +39.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 20.6M +173K +0.85% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 20.6M +135K +0.66% Dec 31, 2014 10-K 2016-03-03
Q3 2014 20.6M +19.2M +1393% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 20.6M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 20.5M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 20.4M +19.1M +1432% Dec 31, 2013 10-K 2015-03-12
Q3 2013 1.38M Sep 30, 2013 10-Q 2013-11-13
Q4 2012 1.33M Dec 31, 2012 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.